The Blocking of c-Met signaling induces apoptosis through the increase of p53 protein in lung cancer

Hae Yun Jung, Hyun Jung Joo, Jong Kuk Park, Yeul Hong Kim

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Purpose: c-Met is an attractive potential target for novel therapeutic inhibition of human cancer, and c-Met tyrosine kinase inhibitors (TKIs) are effective growth inhibitors of various malignancies. However, their mechanisms in anticancer effects are not clear. In the present study, we investigated the possibility that blocking c-Met signaling induces p53-mediated growth inhibition in lung cancer. Materials and Methods: The growth inhibitory effects of c-Met TKI (SU11274) on lung cancer cells and a xenograft model were assessed using the MTT assay, flow cytometry, and terminal deoxyribonucleotide transferase-mediated nick-end labeling staining. The role of p53 protein in the sensitivity of c-Met TKI (SU11274) was examined by Western blot analysis and immunohistochemistry. Results: SU11274 significantly induced apoptosis in A549 cells with wild-type p53, compared with that in Calu-1 cells with null-type p53. SU11274 increased p53 protein by enhancing the stability of p53 protein. Increased p53 protein by SU11274 induced up-regulation of Bax and PUMA expression and down-regulation of Bcl-2 expression, subsequently activating caspase 3. In p53 knock-out and knock-in systems, we confirmed that SU11274 caused apoptosis through the p53-mediated apoptotic pathway. Likewise, in the A549 xenograft model, SU11274 effectively shrank tumor volume and induced apoptosis via increased p53 protein expression. Blocking c-Met signaling increased the level of p53 protein. Conclusion: Our finding suggested that p53 plays an important role in SU11274-induced apoptosis, and p53 status seems to be related to the sensitivity to SU11274 in lung cancer.

Original languageEnglish
Pages (from-to)251-261
Number of pages11
JournalCancer Research and Treatment
Volume44
Issue number4
DOIs
Publication statusPublished - 2012 Dec 1

Fingerprint

Lung Neoplasms
Apoptosis
Proteins
Protein-Tyrosine Kinases
Heterografts
Deoxyribonucleotides
((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
Null Lymphocytes
Growth Inhibitors
Protein Stability
Growth
Transferases
Tumor Burden
Caspase 3
Neoplasms
Flow Cytometry
Up-Regulation
Down-Regulation
Western Blotting
Immunohistochemistry

Keywords

  • ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2 3-dihydro-1H-indole-5-sulfonamide)
  • Apoptosis
  • Lung neoplasms
  • Molecular targeted therapy
  • Tumor suppressor protein p53

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The Blocking of c-Met signaling induces apoptosis through the increase of p53 protein in lung cancer. / Jung, Hae Yun; Joo, Hyun Jung; Park, Jong Kuk; Kim, Yeul Hong.

In: Cancer Research and Treatment, Vol. 44, No. 4, 01.12.2012, p. 251-261.

Research output: Contribution to journalArticle

@article{e0f75a1c7fdb42bf83df07ae03239093,
title = "The Blocking of c-Met signaling induces apoptosis through the increase of p53 protein in lung cancer",
abstract = "Purpose: c-Met is an attractive potential target for novel therapeutic inhibition of human cancer, and c-Met tyrosine kinase inhibitors (TKIs) are effective growth inhibitors of various malignancies. However, their mechanisms in anticancer effects are not clear. In the present study, we investigated the possibility that blocking c-Met signaling induces p53-mediated growth inhibition in lung cancer. Materials and Methods: The growth inhibitory effects of c-Met TKI (SU11274) on lung cancer cells and a xenograft model were assessed using the MTT assay, flow cytometry, and terminal deoxyribonucleotide transferase-mediated nick-end labeling staining. The role of p53 protein in the sensitivity of c-Met TKI (SU11274) was examined by Western blot analysis and immunohistochemistry. Results: SU11274 significantly induced apoptosis in A549 cells with wild-type p53, compared with that in Calu-1 cells with null-type p53. SU11274 increased p53 protein by enhancing the stability of p53 protein. Increased p53 protein by SU11274 induced up-regulation of Bax and PUMA expression and down-regulation of Bcl-2 expression, subsequently activating caspase 3. In p53 knock-out and knock-in systems, we confirmed that SU11274 caused apoptosis through the p53-mediated apoptotic pathway. Likewise, in the A549 xenograft model, SU11274 effectively shrank tumor volume and induced apoptosis via increased p53 protein expression. Blocking c-Met signaling increased the level of p53 protein. Conclusion: Our finding suggested that p53 plays an important role in SU11274-induced apoptosis, and p53 status seems to be related to the sensitivity to SU11274 in lung cancer.",
keywords = "((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2 3-dihydro-1H-indole-5-sulfonamide), Apoptosis, Lung neoplasms, Molecular targeted therapy, Tumor suppressor protein p53",
author = "Jung, {Hae Yun} and Joo, {Hyun Jung} and Park, {Jong Kuk} and Kim, {Yeul Hong}",
year = "2012",
month = "12",
day = "1",
doi = "10.4143/crt.2012.44.4.251",
language = "English",
volume = "44",
pages = "251--261",
journal = "Cancer Research and Treatment",
issn = "1598-2998",
publisher = "Korean Society for Thoracic and Cardiovascular Surgery",
number = "4",

}

TY - JOUR

T1 - The Blocking of c-Met signaling induces apoptosis through the increase of p53 protein in lung cancer

AU - Jung, Hae Yun

AU - Joo, Hyun Jung

AU - Park, Jong Kuk

AU - Kim, Yeul Hong

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Purpose: c-Met is an attractive potential target for novel therapeutic inhibition of human cancer, and c-Met tyrosine kinase inhibitors (TKIs) are effective growth inhibitors of various malignancies. However, their mechanisms in anticancer effects are not clear. In the present study, we investigated the possibility that blocking c-Met signaling induces p53-mediated growth inhibition in lung cancer. Materials and Methods: The growth inhibitory effects of c-Met TKI (SU11274) on lung cancer cells and a xenograft model were assessed using the MTT assay, flow cytometry, and terminal deoxyribonucleotide transferase-mediated nick-end labeling staining. The role of p53 protein in the sensitivity of c-Met TKI (SU11274) was examined by Western blot analysis and immunohistochemistry. Results: SU11274 significantly induced apoptosis in A549 cells with wild-type p53, compared with that in Calu-1 cells with null-type p53. SU11274 increased p53 protein by enhancing the stability of p53 protein. Increased p53 protein by SU11274 induced up-regulation of Bax and PUMA expression and down-regulation of Bcl-2 expression, subsequently activating caspase 3. In p53 knock-out and knock-in systems, we confirmed that SU11274 caused apoptosis through the p53-mediated apoptotic pathway. Likewise, in the A549 xenograft model, SU11274 effectively shrank tumor volume and induced apoptosis via increased p53 protein expression. Blocking c-Met signaling increased the level of p53 protein. Conclusion: Our finding suggested that p53 plays an important role in SU11274-induced apoptosis, and p53 status seems to be related to the sensitivity to SU11274 in lung cancer.

AB - Purpose: c-Met is an attractive potential target for novel therapeutic inhibition of human cancer, and c-Met tyrosine kinase inhibitors (TKIs) are effective growth inhibitors of various malignancies. However, their mechanisms in anticancer effects are not clear. In the present study, we investigated the possibility that blocking c-Met signaling induces p53-mediated growth inhibition in lung cancer. Materials and Methods: The growth inhibitory effects of c-Met TKI (SU11274) on lung cancer cells and a xenograft model were assessed using the MTT assay, flow cytometry, and terminal deoxyribonucleotide transferase-mediated nick-end labeling staining. The role of p53 protein in the sensitivity of c-Met TKI (SU11274) was examined by Western blot analysis and immunohistochemistry. Results: SU11274 significantly induced apoptosis in A549 cells with wild-type p53, compared with that in Calu-1 cells with null-type p53. SU11274 increased p53 protein by enhancing the stability of p53 protein. Increased p53 protein by SU11274 induced up-regulation of Bax and PUMA expression and down-regulation of Bcl-2 expression, subsequently activating caspase 3. In p53 knock-out and knock-in systems, we confirmed that SU11274 caused apoptosis through the p53-mediated apoptotic pathway. Likewise, in the A549 xenograft model, SU11274 effectively shrank tumor volume and induced apoptosis via increased p53 protein expression. Blocking c-Met signaling increased the level of p53 protein. Conclusion: Our finding suggested that p53 plays an important role in SU11274-induced apoptosis, and p53 status seems to be related to the sensitivity to SU11274 in lung cancer.

KW - ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2 3-dihydro-1H-indole-5-sulfonamide)

KW - Apoptosis

KW - Lung neoplasms

KW - Molecular targeted therapy

KW - Tumor suppressor protein p53

UR - http://www.scopus.com/inward/record.url?scp=84873959106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873959106&partnerID=8YFLogxK

U2 - 10.4143/crt.2012.44.4.251

DO - 10.4143/crt.2012.44.4.251

M3 - Article

C2 - 23341789

AN - SCOPUS:84873959106

VL - 44

SP - 251

EP - 261

JO - Cancer Research and Treatment

JF - Cancer Research and Treatment

SN - 1598-2998

IS - 4

ER -